The alliance includes more than 45 cancer centers and academic institutions aiming to expand the use of precision medicine in oncology. At Dana-Farber, it will operate out of the Lank Center for Genitourinary Oncology.
Dana-Farber will work with Caris to develop biomarker-driven trials and improve patient care by leveraging big data, the health system said in a news release.
POA members have access to a comprehensive database and artificial intelligence platform used to develop standards for cancer profiling and molecular testing in oncology.
More articles on oncology:
Breast cancer death rates stop declining in younger women, study finds
Cleveland Clinic oncologist reflects on the evolution of cancer care: 4 notes
Dartmouth’s cancer center installs radiation vision cameras
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
